Search research articles
Contact Us
Filters
Showing results (451-460 of 1,137) with videos related to
Page
of 114
Sort By:
Journal of the American College of Cardiology
|
June 17, 1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction
D A Morrow, N Rifai, E M Antman, et al.
Antisense & Nucleic Acid Drug Development
|
July 21, 1998
A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation
W Wang, H J Chen, J Sun, et al.
JAMA Network Open
|
April 29, 2022
Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis
Bahar Behrouzi, Deepak L Bhatt, Christopher P Cannon, et al.
American Heart Journal
|
June 24, 2010
Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program
Mladen I Vidovich, Samip Vasaiwala, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)
Payal Kohli, Jacob A Udell, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism
|
February 17, 2017
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II
Lawrence A Leiter, José Luis Zamorano, Maja Bujas-Bobanovic, et al.
Journal of the American College of Cardiology
|
February 17, 2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy
D A Morrow, N Rifai, E M Antman, et al.
Journal of Thrombosis and Thrombolysis
|
October 6, 2007
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
Benjamin A Olenchock, Stephen D Wiviott, Sabina A Murphy, et al.
The American Journal of Cardiology
|
August 25, 2004
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy)
C Michael Gibson, Kanwar P Singh, Sabina A Murphy, et al.
American Heart Journal
|
January 7, 2003
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry
Maria Cecilia Bahit, Christopher P Cannon, Elliott M Antman, et al.
Page
of 114
Search research articles
Search
Showing results (451-460 of 1,137) with videos related to
Sort By:
Page
of 114
Journal of the American College of Cardiology
|
June 17, 1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction
D A Morrow, N Rifai, E M Antman, et al.
Antisense & Nucleic Acid Drug Development
|
July 21, 1998
A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation
W Wang, H J Chen, J Sun, et al.
JAMA Network Open
|
April 29, 2022
Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis
Bahar Behrouzi, Deepak L Bhatt, Christopher P Cannon, et al.
American Heart Journal
|
June 24, 2010
Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program
Mladen I Vidovich, Samip Vasaiwala, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)
Payal Kohli, Jacob A Udell, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism
|
February 17, 2017
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II
Lawrence A Leiter, José Luis Zamorano, Maja Bujas-Bobanovic, et al.
Journal of the American College of Cardiology
|
February 17, 2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy
D A Morrow, N Rifai, E M Antman, et al.
Journal of Thrombosis and Thrombolysis
|
October 6, 2007
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
Benjamin A Olenchock, Stephen D Wiviott, Sabina A Murphy, et al.
The American Journal of Cardiology
|
August 25, 2004
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy)
C Michael Gibson, Kanwar P Singh, Sabina A Murphy, et al.
American Heart Journal
|
January 7, 2003
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry
Maria Cecilia Bahit, Christopher P Cannon, Elliott M Antman, et al.
Page
of 114